People's United Financial’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$409K Buy
2,281
+1,027
+82% +$196K 0.01% 485
2021
Q4
$271K Sell
1,254
-672
-35% -$132K 0.01% 600
2021
Q3
$356K Buy
1,926
+230
+14% +$45.3K 0.01% 583
2021
Q2
$304K Buy
1,696
+227
+15% +$43.2K 0.01% 607
2021
Q1
$246K Buy
+1,469
New +$245K 0.01% 634
2016
Q2
Sell
-100
Closed -$11K 912
2016
Q1
$11K Hold
100
﹤0.01% 710
2015
Q4
$16K Buy
+100
New +$14.6K ﹤0.01% 677
2014
Q2
Sell
-100
Closed -$9K 827
2014
Q1
$9K Hold
100
﹤0.01% 685
2013
Q4
$11K Hold
100
﹤0.01% 658
2013
Q3
$8K Buy
+100
New +$7.31K ﹤0.01% 692

Other funds holding UTHR

People's United Financial's UTHR Position: Q1 2022 in Review

People's United Financial increased its United Therapeutics (UTHR) stake by 82% in Q1 2022, buying an estimated $196K and bringing the position to 2,281 shares worth $409K. The position accounts for 0.01% of the portfolio, ranked #485.

People's United Financial first reported a position in UTHR in Q3 2013 and has held it in 10 quarters since. 428 funds tracked by Wall St. Rank hold UTHR as of Q1 2022.

  • People's United Financial held 2,281 shares of United Therapeutics worth $409K as of Q1 2022.
  • People's United Financial bought 1,027 United Therapeutics shares in Q1 2022, an estimated $196K.
  • United Therapeutics made up 0.01% of People's United Financial's portfolio in Q1 2022, its #485 holding.
  • People's United Financial first reported a position in United Therapeutics in Q3 2013 and has held it in 10 quarters since.
  • 428 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2022.

Based on People's United Financial's 13F filing for Q1 2022, filed 10 May 2022.